Dongyi Du - Concepedia

Author

Dongyi Du

Center for Biologics Evaluation and Research

Also Known As

D Du, D. Du, Dongyi (Tony) Du, Dongyi Du, Dongyi T. Du, Dongyi “Tony” Du, Dongzhou Du

Publications

440

Citations

H-Index

Concepts

All Affiliations

Center for Biologics Evaluation and Research United States Food and Drug Administration Agency for Healthcare Research and Quality University of Maryland, Baltimore Centers for Medicare and Medicaid Services

About

Dongyi Du is an author at Center for Biologics Evaluation and Research specializing in medicine, public health, and health insurance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	136
2	Public Health	2	2	68
3	Allergy	1	1	52
4	Epidemiology	1	1	16
5	Health Law	1	1	16

Dongyi Du

Publications

419

Citations

H-Index

Page 1

	Year	Citations
Recent Improvements in Bariatric Surgery Outcomes William Encinosa, Didem Bernard, Dongyi Du, Medical Care	2009	152
Incidence of Endophthalmitis after Corneal Transplant or Cataract Surgery in a Medicare Population Dongyi Du, Austin Wagoner, Samuel B. Barone, Ophthalmology Transplantation SurgeryOphthalmic SurgeryMedicare PopulationOphthalmologyCataract Surgery	2013	68
Burden of COPD, Asthma, and Concomitant COPD and Asthma Among Adults Fadia T. Shaya, Mark S. Maneval, Confidence M. Gbarayor, CHEST Journal AsthmaPulmonary CareAllergyAdvanced Lung DiseaseRespiratory Diseases	2009	52
Risk Factors for Surgical Site Infections Following Anterior Cruciate Ligament Reconstruction Michael Murphy, Dongyi Du, Wei Hua, Infection Control and Hospital Epidemiology	2016	35
Early Mortality After Aortic Valve Replacement With Mechanical Prosthetic vs Bioprosthetic Valves Among Medicare Beneficiaries Dongyi Du, Stephen McKean, Jeffrey A. Kelman, JAMA Internal Medicine	2014	30
Drug therapy persistence and stroke recurrence. Fadia T. Shaya, Antoine C. El Khoury, C. Daniel Mullins, PubMed	2006	27
Development of a Nationally Representative Coordinated Registry Network for Prostate Ablation Technologies Ron Golan, Adrien Bernstein, Art Sedrakyan, The Journal of Urology	2018	21
Atomoxetine Use During a Period of FDA Actions Dongyi Du, Esther H. Zhou, John Goldsmith, Medical Care	2012	18
Despite 2007 Law Requiring FDA Hotline To Be Included In Print Drug Ads, Reporting Of Adverse Events By Consumers Still Low Dongyi Du, John Goldsmith, Kathryn J. Aikin, Health Affairs Print Drug AdsHealth LawHarm ReductionAdverse Drug ReactionPrescription Drug	2012	16

Page 1